S.1239 - Scleroderma Research and Awareness Act113th Congress (2013-2014)
|Sponsor:||Sen. Gillibrand, Kirsten E. [D-NY] (Introduced 06/27/2013)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||06/27/2013 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Subject — Policy Area:
- View subjects
Summary: S.1239 — 113th Congress (2013-2014)All Bill Information (Except Text)
Introduced in Senate (06/27/2013)
Scleroderma Research and Awareness Act - Requires the Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases to expand, intensify, and coordinate the Institute's activities with respect to scleroderma, with particular emphasis on: (1) research focused on the etiology of scleroderma and the development of new treatment options, (2) clinical research to evaluate new treatment options, (3) basic research on the relationship between scleroderma and secondary conditions, (4) establishment of scleroderma patient registries, and (5) support for training of new clinicians and investigators with expertise in scleroderma.
Directs the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out an educational campaign to increase public awareness of scleroderma.